Web Analytics

3 Latest Announced Rounds

  • $2,500,000
    Seed

    3 Investors

    Construction
    Oct 23rd, 2025
  • $21,000,000
    Series A

    2 Investors

    Software Development
    Oct 22nd, 2025
  • $55,000,000
    Series A

    2 Investors

    Renewable Energy Power Generation
    Oct 22nd, 2025
$917.60M Raised in 47 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Athernal Bio

start up
United Kingdom - Cambridge
  • 02/10/2025
  • Unknown
  • $4,718,630

Developing targeted immunotherapies to treat high-risk clonal haematopoiesis (CH)—the precursor to blood cancers—so we can stop cancer before it starts.


Related People

Colin FreundFounder

Colin Freund United States - New York City Metropolitan Area

C-level executive with experience in both private and public biotechnology companies, with 18 years' experience leading multinational teams that drive revenue generation and corporate value creation: company leadership (including venture fundraising); strategic planning, business/corporate development and M&A ($500M+ in multiple licensing/M&A transactions); corporate restructuring; alliance management; commercial development and product launch preparation; supply chain optimization; organizational development; investor relations/fundraising; and business interface on regulatory strategy in the USA, Europe and Asia.